SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending following a Goldman Sachs downgrade to a "Sell" rating and a $26 price target, which the community widely perceives as an attempt to manipulate shares. Despite concerns over profitability and competition raised by the downgrade, many highlight SMCI's critical role in the expanding AI infrastructure market, anticipating strong revenue growth in upcoming earnings to affirm its undervalued position.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending after an analyst upgrade highlighted robust hyperscaler demand and projected sell-outs of its server CPUs for future periods, signaling strong momentum in its AI accelerator pipeline. This news is fueling optimistic community discussions about significant market share gains and potential for continued growth. However, a segment of the community remains cautious, citing the stock's historical volatility and intense competition within the semiconductor industry.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Corp

BriaCell Therapeutics is trending following news of an upcoming 1-for-10 reverse stock split, stirring significant community concern over its history of repeated dilutions and share price depreciation. Despite recent positive announcements, including a $2 million NCI grant and peer-reviewed publication on its cancer immunotherapies, widespread skepticism persists regarding management's financing strategies. This situation underscores the ongoing tension in clinical-stage biotech between funding scientific advancement and maintaining investor confidence.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is a major talking point following its strong quarterly earnings, which showcased robust trading revenue and record performance in its wealth management division, exceeding market expectations. The community is buzzing about the strategic acquisition of the Apple Card portfolio and CEO Jamie Dimon's cautiously optimistic economic commentary, with ongoing speculation about a potential stock split and new ventures into crypto.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending following strong preliminary Q4 2025 revenue results, generating significant community buzz around its potential for major defense contracts. Investors are highly optimistic about RCAT's Black Widow drones, speculating on their recent use in military operations and eagerly anticipating awards from the upcoming Drone Dominance Program, with many also noting high short interest and perceived undervaluation.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

AHMA is experiencing explosive price action and massive trading volume, with many in the community noting a lack of specific news driving the surge. Discussions revolve around its extremely low float and recent IPO status, leading to speculation about a potential short squeeze reminiscent of other highly volatile low-float runners. Traders are actively debating scalping opportunities versus holding for substantial gains, alongside cautious warnings of potential manipulation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending following a softer-than-expected core CPI report, signaling inflation may be cooling faster than anticipated. This dovish surprise is fueling widespread market optimism and driving expectations for a strong rally, despite some community members expressing skepticism about the reported economic data. Discussions revolve around whether this signals continued upside or if underlying economic concerns will eventually lead to a shift.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending after signaling an operating inflection with substantially raised 2026 revenue guidance, bolstered by recent acquisitions and increasing contracted demand. The community is actively discussing the company's long-term potential within the booming AI and drone defense sector, anticipating significant military contracts and a possible short squeeze. This strategic update highlights the company's positioning to capitalize on the growing demand for embedded AI and autonomous solutions, despite ongoing debates over current revenue figures and market volatility.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as inflation data largely met expectations, fueling a robust market rally and an active debate between bulls celebrating its resilience and skeptics alleging manipulation. The community is buzzing about the market's seemingly unstoppable upward momentum, often citing a pervasive 'buy the dip' mentality even amidst discussions of political pressures on the Federal Reserve and new tariff threats.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is seeing strong interest due to its strategic refocus on high-margin AI and rugged edge compute, marked by a significant pre-production order from a major U.S. defense contractor and the sale of its European subsidiary. The community is actively discussing the potential for much larger follow-on defense contracts, with many investors anticipating substantial growth as the market recognizes OSS as an undervalued pure-play in the critical AI-in-defense sector. This confluence of recent business developments, real customer validation, and a low float has ignited bullish sentiment around its long-term momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High - Here's Why

Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year High - Time to Buy...

Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume Increase - What's Next?

Alpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading Volume - Here's Why...

Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation

Radiation therapy has been a foundation of cancer care for more than a century. From early X-ray machines to today&#8217;s image-guided systems, the goal has remained the same: deliver enough energy to destroy tumors while sparing healthy tissue. What has changed, gradually, then suddenly, is the level of precision clinicians can bring to that task. A new generation of technologies is pushing radiation beyond its historical limits, opening therapeutic possibilities for patients who previously had few or no options.&nbsp;Alpha Tau Medical Ltd. (Nasdaq: DRTS) sits at the center of that ...

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 58.8% in December

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling...

Alpha Tau Medical (NASDAQ:DRTS) Given New $7.00 Price Target at Citigroup

Citigroup reduced their target price on shares of Alpha Tau Medical from $8.00 to $7.00 and set a "buy" rating for the company in a research note on Wednesday...

Why Did Alpha Tau Medical (DRTS) Shares Jump Over 25% In After-Hours Trading?

Alpha Tau Medical surged in after-hours trading after treating the first patient in its pilot study for recurrent glioblastoma with Alpha DaRT therapy.read more...

Alpha Tau Medical (NASDAQ:DRTS) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.12) by...

Alpha Tau Medical Ltd. shares hit their highest level on Monday in three months following the company's report of a smaller-than-expected quarterly loss and advances in several U.S. FDA-approved clinical trials.The stock rose 11.1% to close at $3.10 and extended gains by another 6.5% to $3.30 in after-hours trading.For the first quarter ending March 31, the company posted a net loss of $8.7 million, equivalent to $0.12 per share,&nbsp;widening from a loss of $8.0 million or $0.11 per share&nbsp;a year earlier.According to The Fly, analysts expected Alpha Tau Medical to report a&nbsp;bigger loss of $0.13 per share.The company's financial income rose to $0.7 million from $0.4 million in the previous year due to reduced warrant remeasurement expenses,&nbsp;offsetting the decrease in interest income from deposits.Alpha Tau's regulatory achievements, including four active FDA Investigational Device Exemptions (IDEs) and upcoming U.S. trials for pancreatic cancer along with recurrent glioblastoma multiforme (GBM), generated positive investor response, which led to share price increases even though financial losses continued.CEO Uzi Sofer said that 2025 started with significant milestones,&nbsp;such as facility expansion in New Hampshire and strong clinical advancements,&nbsp;which received support from a $36.9 million capital increase.On Stocktwits, retail sentiment was ‘bearish’ amid ‘high’ message volume.The stock has remained flat so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Israel-based biopharma reported positive final results from a randomized Phase 2 study of its lead oncology drug, CM24, in patients with pancreatic ductal adenocarcinoma.

Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish

The company’s stock surged to a three-month high following its Q1 report, progress in FDA-approved clinical trials, and a recent capital raise.

Equity

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

DRTS
ALPHA TAU MEDICAL LTD

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DRTS News

DRTSALPHA TAU MEDICAL LTD